Contact this trialFirst, we need to learn more about you.
Immunotherapy
DPCP for Neurofibromatosis
Recruiting1 awardPhase 1
New York, New York
This trial is researching a new treatment for neurofibromatosis, which is a disorder that causes tumors to form on the nerves. The treatment is a topical medication that is applied to the skin once a week, and the trial will test the safety and effectiveness of the medication.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.